Cargando…

Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer

BACKGROUND: Ferroptosis is a newly defined form of programmed cell death that plays an important role in many cancers. However, ferroptosis-related lncRNAs (FRLs) involved in the regulation of colon cancer are not thoroughly understood. This study aimed to identify a prognostic FRL signature in colo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zhiwei, Lu, Zhixing, Li, Liang, Ma, Min, Long, Fei, Wu, Runliu, Huang, Lihua, Chou, Jing, Yang, Kaiyan, Zhang, Yi, Li, Xiaorong, Hu, Gui, Lin, Changwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826443/ https://www.ncbi.nlm.nih.gov/pubmed/35154072 http://dx.doi.org/10.3389/fimmu.2021.783362

Ejemplares similares

LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM
por: Fu, Haijuan, et al.
Publicado: (2022)

Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment
por: Wu, Zhiwei, et al.
Publicado: (2022)

COL5A1 Promotes the Progression of Gastric Cancer by Acting as a ceRNA of miR-137-3p to Upregulate FSTL1 Expression
por: Yang, Ming, et al.
Publicado: (2022)

Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma
por: Li, Hong, et al.
Publicado: (2021)

PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability
por: Xie, Canbin, et al.
Publicado: (2022)

Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma
por: Guo, Sen, et al.
Publicado: (2022)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma
por: Guo, Yugang, et al.
Publicado: (2021)

Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer
por: Qu, Ailin, et al.
Publicado: (2023)

Identification of a ferroptosis-related lncRNA signature with prognosis for Wilms tumor
por: Liu, Hengchen, et al.
Publicado: (2021)

Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: Zhou, Xin-Ying, et al.
Publicado: (2022)

Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer
por: Cai, Hua-jun, et al.
Publicado: (2021)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer
por: Wu, Hao, et al.
Publicado: (2017)

A Prognostic Ferroptosis-Related lncRNA Model Associated With Immune Infiltration in Colon Cancer
por: Lu, Jianzhong, et al.
Publicado: (2022)

Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer
por: Lai, Donglin, et al.
Publicado: (2022)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response
por: Liu, Xiaoxiao, et al.
Publicado: (2021)

A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients
por: Peng, Jing, et al.
Publicado: (2021)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
por: Yao, Jie, et al.
Publicado: (2021)

Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma
por: Lu, Lu, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

A Novel Prognostic Ferroptosis-Related lncRNA Signature Associated with Immune Landscape in Invasive Breast Cancer
por: Shen, Shuang, et al.
Publicado: (2022)

Corrigendum: Prognostic ferroptosis-related lncRNA signatures associated with immunotherapy and chemotherapy responses in patients with stomach cancer
por: Lai, Donglin, et al.
Publicado: (2022)

Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: International, BioMed Research
Publicado: (2022)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Corrigendum: A novel ferroptosis-related LncRNA pair prognostic signature predicts immune landscapes and treatment responses for gastric cancer patients
por: Li, Jiazheng, et al.
Publicado: (2022)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification and Validation of Ferroptosis-Related LncRNAs Signature as a Novel Prognostic Model for Chronic Lymphocytic Leukemia
por: Xu, Zhangdi, et al.
Publicado: (2023)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma
por: Guo, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_on12otb09j6728u0net91imdhb